J P Bader|D Hell - JoVE Visualize

Showing results (81-90 of 128) with videos related to

Pageof 13

Sort By:

Depression and Anxiety|March 14, 2002

Prepulse inhibition deficits in patients with panic disorderS Ludewig, K Ludewig, M A Geyer, et al.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 1997

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)F X Vollenweider, K L Leenders, I Oye, et al.

Journal of Natural Products|June 30, 2001

Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics programS S Yang, G M Cragg, D J Newman, et al.

Leukemia|October 1, 1995

Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activityS S Yang, V Fliakas-Boltz, J P Bader, et al.

Gastroenterologie Clinique Et Biologique|October 1, 1988

[Epigastric pain and regurgitation: descriptive epidemiology in a representative sample of the adult population of France]S Bruley des Varannes, J P Galmiche, P Bernades, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2000

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humansM E Liechti, M R Saur, A Gamma, et al.

Neuroreport|January 6, 1999

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist actionF X Vollenweider, M F Vollenweider-Scherpenhuyzen, A Bäbler, et al.

European Archives of Psychiatry and Clinical Neuroscience|August 17, 1999

A deviant EEG brain microstate in acute, neuroleptic-naive schizophrenics at restT Koenig, D Lehmann, M C Merlo, et al.

Archives of General Psychiatry|December 15, 2000

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophreniaD Umbricht, L Schmid, R Koller, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2000

3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humansA Gamma, A Buck, T Berthold, et al.

Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:

Pageof 13

Depression and Anxiety|March 14, 2002

Prepulse inhibition deficits in patients with panic disorderS Ludewig, K Ludewig, M A Geyer, et al.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 1997

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)F X Vollenweider, K L Leenders, I Oye, et al.

Journal of Natural Products|June 30, 2001

Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics programS S Yang, G M Cragg, D J Newman, et al.

Leukemia|October 1, 1995

Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activityS S Yang, V Fliakas-Boltz, J P Bader, et al.

Gastroenterologie Clinique Et Biologique|October 1, 1988

[Epigastric pain and regurgitation: descriptive epidemiology in a representative sample of the adult population of France]S Bruley des Varannes, J P Galmiche, P Bernades, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2000

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humansM E Liechti, M R Saur, A Gamma, et al.

Neuroreport|January 6, 1999

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist actionF X Vollenweider, M F Vollenweider-Scherpenhuyzen, A Bäbler, et al.

European Archives of Psychiatry and Clinical Neuroscience|August 17, 1999

A deviant EEG brain microstate in acute, neuroleptic-naive schizophrenics at restT Koenig, D Lehmann, M C Merlo, et al.

Archives of General Psychiatry|December 15, 2000

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophreniaD Umbricht, L Schmid, R Koller, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2000

3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humansA Gamma, A Buck, T Berthold, et al.

Pageof 13